The biotechnology company Oxolife S.L. (Spain), the Energy Balance, Puberty and Reproductive Health research group of … [Read more...] about Oxolife initiates a collaboration with the University of Cordoba and Rutgers, The State University of New Jersey, to develop a treatment to improve women’s fertility
ANOTHER BIG MILESTONE FOR OXOLIFE
We are delighted to announce that OXOART2, the OXO-001 phase II clinical trial, has already started! As mentioned by … [Read more...] about ANOTHER BIG MILESTONE FOR OXOLIFE
Good feelings in the investigators meetings
On the 9th of September, we had the pleasure to meet the Czech and Polish investigators in the OXOART2 Investigators … [Read more...] about Good feelings in the investigators meetings
OXOART2 is here: First Investigators Meeting
Last Thursday 2nd of September, we had the pleasure to celebrate the first investigator meeting of the phase II clinical … [Read more...] about OXOART2 is here: First Investigators Meeting
UNPRECEDENTED APPROACH: Oxolife shows up in El Punt Avui
OXOLIFE is developing the first drug that will treat female infertility by improving the endometrium to enhance the … [Read more...] about UNPRECEDENTED APPROACH: Oxolife shows up in El Punt Avui
OXOLIFE presents the latest results in the ASRM21
Oxolife will present its newest evidences on OXO-001 in fertility and embryo implantation in the American Society for … [Read more...] about OXOLIFE presents the latest results in the ASRM21